Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(9):712-713; doi:10.1093/jnci/djh114
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by van der Groep, P.
Right arrow Articles by van Diest, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Groep, P.
Right arrow Articles by van Diest, P. J.
Related Collections
Right arrowCorrespondence about this Article
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

Petra van der Groep, Alwin Bouter, Richard van der Zanden, Fred H. Menko, Horst Buerger, Rene H.M. Verheijen, Elsken van der Wall, Paul J. van Diest

Affiliations of authors: Department of Medical Oncology (PVDG, EVDW), Department of Pathology (PVDG, AB, PVDZ, PJVD), Department of Clinical Genetics (FHM), Department of Gynecology and Obstetrics (RHMV), VU University Medical Center, Amsterdam, The Netherlands; Department of Pathology, Gerhard Domagk University, Muenster, Germany (HB).

Correspondence to: Paul J. van Diest, MD, PhD, Department of Pathology, University Medical Center, P.O. Box 85500, NL 3508 GA, Utrecht, The Netherlands (e-mail: p.j.vandiest@lab.azu.nl)

The first 10% of the full text of this article appears below.

Foulkes et al. (1) reported that the expression of cytokeratin 5/6, indicating a basal epithelial phenotype, was statistically significantly associated with germline BRCA1 mutations in estrogen receptor (ER)- and erbB2-negative invasive breast cancers. It has recently been shown that the epidermal growth factor receptor (EGFR) is . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
José Palacios, Emiliano Honrado, Ana Osorio, Orland Diez, Carmen Rivas, and Javier Benítez
J Natl Cancer Inst 2004 96: 712-714. [Extract] [Full Text] [PDF]

RESPONSE: Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
William D. Foulkes and Lars A. Akslen
J Natl Cancer Inst 2004 96: 714. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
D S P Tan, C Marchio, and J S Reis-Filho
Hereditary breast cancer: from molecular pathology to tailored therapies
J. Clin. Pathol., October 1, 2008; 61(10): 1073 - 1082.
[Abstract] [Full Text] [PDF]